|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fong Y, Cohen AM, Fortner JG, Enker WE,
Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH and Brennan
MF: Liver resection for colorectal metastases. J Clin Oncol.
15:938–946. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rajput A and Bullard Dunn K: Surgical
management of rectal cancer. Semin Oncol. 34:241–249. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weiser MR, Landmann RG, Wong WD, Shia J,
Guillem JG, Temple LK, Minsky BD, Cohen AM and Paty PB: Surgical
salvage of recurrent rectal cancer after transanal excision. Dis
Colon Rectum. 48:1169–1175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wiig JN, Larsen SG and Giercksky KE:
Operative treatment of locally recurrent rectal cancer. Recent
Results Cancer Res. 165:136–147. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schrag D, Weiser MR, Goodman KA, Gonen M,
Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem
JG, et al: Neoadjuvant chemotherapy without routine use of
radiation therapy for patients with locally advanced rectal cancer:
A pilot trial. J Clin Oncol. 32:513–518. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Glynne-Jones R, Hava N, Goh V, Bosompem S,
Bridgewater J, Chau I, Gaya A, Wasan H, Moran B, Melcher L, et al:
Bevacizumab and Combination Chemotherapy in rectal cancer Until
Surgery (BACCHUS): A phase II, multicentre, open-label, randomised
study of neoadjuvant chemotherapy alone in patients with high-risk
cancer of the rectum. BMC Cancer. 15:7642015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kamiya T, Uehara K, Nakayama G, Ishigure
K, Kobayashi S, Hiramatsu K, Nakayama H, Yamashita K, Sakamoto E,
Tojima Y, et al: Early results of multicenter phase II trial of
perioperative oxaliplatin and capecitabine without radiotherapy for
high-risk rectal cancer: CORONA I study. Eur J Surg Oncol.
42:829–835. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Folkesson J, Birgisson H, Pahlman L,
Cedermark B, Glimelius B and Gunnarsson U: Swedish Rectal Cancer
Trial: Long lasting benefits from radiotherapy on survival and
local recurrence rate. J Clin Oncol. 23:5644–5650. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peeters KC, Marijnen CA, Nagtegaal ID,
Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius
B, Leer JW, et al: The TME trial after a median follow-up of 6
years: Increased local control but no survival benefit in
irradiated patients with resectable rectal carcinoma. Ann Surg.
246:693–701. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sauer R, Liersch T, Merkel S, Fietkau R,
Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann
H, et al: Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: Results of the German
CAO/ARO/AIO-94 randomized phase III trial after a median follow-up
of 11 years. J Clin Oncol. 30:1926–1933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ciseł B, Pietrzak L, Michalski W, Wyrwicz
L, Rutkowski A, Kosakowska E, Cencelewicz A, Spałek M, Polkowski W,
Jankiewicz M, et al: Long-course preoperative chemoradiation versus
5x5 Gy and consolidation chemotherapy for clinical T4 and fixed
clinical T3 rectal cancer: Long-term results of the randomized
Polish II study. Ann Oncol. 30:1298–1303. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bahadoer RR, Dijkstra EA, van Etten B,
Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID,
Beets-Tan RGH, Blomqvist LK, et al: Short-course radiotherapy
followed by chemotherapy before total mesorectal excision (TME)
versus preoperative chemoradiotherapy, TME, and optional adjuvant
chemotherapy in locally advanced rectal cancer (RAPIDO): A
randomised, open-label, phase 3 trial. Lancet Oncol. 22:29–42.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin J, Tang Y, Hu C, Jiang LM, Jiang J, Li
N, Liu WY, Chen SL, Li S, Lu NN, et al: Multicenter, randomized,
Phase III trial of short-term radiotherapy plus chemotherapy versus
long-term chemoradiotherapy in locally advanced rectal cancer
(STELLAR). J Clin Oncol. 40:1681–1692. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Patel UB, Taylor F, Blomqvist L, George C,
Evans H, Tekkis P, Quirke P, Sebag-Montefiore D, Moran B, Heald R,
et al: Magnetic resonance imaging-detected tumor response for
locally advanced rectal cancer predicts survival outcomes: MERCURY
experience. J Clin Oncol. 29:3753–3760. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fokas E, Liersch T, Fietkau R, Hohenberger
W, Beissbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S, et
al: Tumor regression grading after preoperative chemoradiotherapy
for locally advanced rectal carcinoma revisited: Updated results of
the CAO/ARO/AIO-94 trial. J Clin Oncol. 32:1554–1562. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghadimi BM, Grade M, Difilippantonio MJ,
Varma S, Simon R, Montagna C, Füzesi L, Langer C, Becker H, Liersch
T, et al: Effectiveness of gene expression profiling for response
prediction of rectal adenocarcinomas to preoperative
chemoradiotherapy. J Clin Oncol. 23:1826–1838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cercek A, Dos Santos Fernandes G, Roxburgh
CS, Ganesh K, Ng S, Sanchez-Vega F, Yaeger R, Segal NH,
Reidy-Lagunes DL, Varghese AM, et al: Mismatch repair-deficient
rectal cancer and resistance to neoadjuvant chemotherapy. Clin
Cancer Res. 26:3271–3279. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lynch ML and Brand MI: Preoperative
evaluation and oncologic principles of colon cancer surgery. Clin
Colon Rectal Surg. 18:163–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arteaga-González I, Martín-Malagón A,
Fernández EM, Arranz-Durán J, Parra-Blanco A, Nicolas-Perez D,
Quintero-Carrión E, Luis HD and Carrillo-Pallares A: The use of
preoperative endoscopic tattooing in laparoscopic colorectal cancer
surgery for endoscopically advanced tumors: A prospective
comparative clinical study. World J Surg. 30:605–611. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
LeCun Y, Bengio Y and Hinton G: Deep
learning. Nature. 521:436–444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duch W, Swaminathan K and Meller J:
Artificial intelligence approaches for rational drug design and
discovery. Curr Pharm Des. 13:1497–1508. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ehteshami Bejnordi B, Veta M, Johannes van
Diest P, van Ginneken B, Karssemeijer N, Litjens G, van der Laak J,
Hermsen M, Manson QF, Balkenhol M, et al: Diagnostic assessment of
deep learning algorithms for detection of lymph node metastases in
women with breast cancer. JAMA. 318:2199–2210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khosravi P, Kazemi E, Imielinski M,
Elemento O and Hajirasouliha I: Deep Convolutional neural networks
enable discrimination of heterogeneous digital pathology images.
EBioMedicine. 27:317–328. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhinder B, Gilvary C, Madhukar NS and
Elemento O: Artificial intelligence in cancer research and
precision medicine. Cancer Discov. 11:900–915. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
TNM Classifcation of Maligant Tumours,
Eighth Edition. Wiley Blackwell; Hoboken: 2016
|
|
27
|
Yukimoto R, Uemura M, Tsuboyama T, Sekido
Y, Hata T, Ogino T, Miyoshi N, Takahashi H, Kida A, Furuyashiki M,
et al: Efficacy of PET/CT in diagnosis of regional lymph node
metastases in patients with colorectal cancer: Retrospective cohort
study. BJS Open. 6:2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Japanese Classification of Colorectal,
Appendiceal and Anal Carcinoma: The 3d English Edition [Secondary
Publication]. J Anus Rectum Colon. 3:175–195. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Benson AB, Venook AP, Al-Hawary MM, Azad
N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D,
Garrido-Laguna I, et al: Rectal cancer, version 2.2022, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
20:1139–1167. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krizhevsky AS and Hinton GEI: Imagenet
classification with deep convolutional neural networks. Adv Neural
Inf Process Syst. 25:1097–1105. 2012.PubMed/NCBI
|
|
32
|
Minami S, Saso K, Miyoshi N, Fujino S,
Kato S, Sekido Y, Hata T, Ogino T, Takahashi H, Uemura M, et al:
Diagnosis of depth of submucosal invasion in colorectal cancer with
AI using deep learning. Cancers (Basel). 14:53612022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamashita R, Long J, Longacre T, Peng L,
Berry G, Martin B, Higgins J, Rubin DL and Shen J: Deep learning
model for the prediction of microsatellite instability in
colorectal cancer: A diagnostic study. Lancet Oncol. 22:132–141.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiao Y, Li J, Qian C and Fei S: Deep
learning-based tumor microenvironment analysis in colon
adenocarcinoma histopathological whole-slide images. Comput Methods
Programs Biomed. 204:1060472021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gupta R, Srivastava D, Sahu M, Tiwari S,
Ambasta RK and Kumar P: Artificial intelligence to deep learning:
Machine intelligence approach for drug discovery. Mol Divers.
25:1315–1360. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu X, Zhang D, Liu Z, Li Z, Xie P, Sun K,
Wei W, Dai W, Tang Z, Ding Y, et al: Deep learning radiomics-based
prediction of distant metastasis in patients with locally advanced
rectal cancer after neoadjuvant chemoradiotherapy: A multicentre
study. EBioMedicine. 69:1034422021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feng L, Liu Z, Li C, Li Z, Lou X, Shao L,
Wang Y, Huang Y, Chen H, Pang X, et al: Development and validation
of a radiopathomics model to predict pathological complete response
to neoadjuvant chemoradiotherapy in locally advanced rectal cancer:
A multicentre observational study. Lancet Digit Health. 4:e8–e17.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Miyoshi N: AI application for surgery. J
Jpn Soc Precis Eng. 88:9–11. 2022. View Article : Google Scholar
|
|
39
|
Lu L, Dercle L, Zhao B and Schwartz LH:
Deep learning for the prediction of early on-treatment response in
metastatic colorectal cancer from serial medical imaging. Nat
Commun. 12:66542021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Horvat N, Veeraraghavan H, Khan M, Blazic
I, Zheng J, Capanu M, Sala E, Garcia-Aguilar J, Gollub MJ and
Petkovska I: MR Imaging of rectal cancer: Radiomics analysis to
assess treatment response after neoadjuvant therapy. Radiology.
287:833–843. 2018. View Article : Google Scholar : PubMed/NCBI
|
